These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
88 results:

  • 1. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
    Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
    BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PD-L1 Expression in colorectal Carcinoma Correlates with the Immune Microenvironment.
    Shahin M; Patra S; Purkait S; Kar M; Das Majumdar SK; Mishra TS; Samal SC; Nayak HK
    J Gastrointest Cancer; 2024 Jun; 55(2):940-949. PubMed ID: 38530597
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
    Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
    Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. scRNA-seq of colorectal cancer shows regional immune atlas with the function of cd20
    Ji L; Fu G; Huang M; Kao X; Zhu J; Dai Z; Chen Y; Li H; Zhou J; Chu X; Lei Z
    Cancer Lett; 2024 Mar; 584():216664. PubMed ID: 38253219
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Role of High Mobility Group Box B-1 in the prognosis of colorectal cancer Based on the Changes in the Intestinal Mucosal Barrier.
    Zhao W; Chen A; Yuan N; Hao X; Wang C; Lu X; Song X; Zhang Z
    Technol Cancer Res Treat; 2024; 23():15330338231198972. PubMed ID: 38200714
    [No Abstract]    [Full Text] [Related]  

  • 7. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
    Edin S; Gylling B; Li X; Stenberg Å; Löfgren-Burström A; Zingmark C; van Guelpen B; Ljuslinder I; Ling A; Palmqvist R
    Br J Cancer; 2024 Jan; 130(1):143-150. PubMed ID: 38040818
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deficiency of SR-B1 reduced the tumor load of colitis-induced or APC
    Chen Q; Wang L; Song H; Xing W; Shi J; Li Y; Wang Z; Chen J; Xie N; Zhao W
    Cancer Med; 2023 Oct; 12(19):19744-19757. PubMed ID: 37766594
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer.
    Lu Y; Zou R; Gu Q; Wang X; Zhang J; Ma R; Wang T; Wu J; Feng J; Zhang Y
    Cell Death Dis; 2023 Sep; 14(9):611. PubMed ID: 37716979
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
    Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
    Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon cancers and 5-FU Resistance.
    Cui Z; He S; Wen F; Lu L; Xu L; Wu H; Wu S
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):80. PubMed ID: 37114540
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in colorectal cancer Liver Metastasis.
    Zhang D; Chen Z; Zhang L; Qian X; Huang X; Zheng Z; Pan W
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939250
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
    Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
    BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of potential biomarkers for colorectal cancer by clinical database analysis and Kaplan-Meier curves analysis.
    Li C; Gao Y; Lu C; Guo M
    Medicine (Baltimore); 2023 Feb; 102(6):e32877. PubMed ID: 36820595
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A prognostic score based on B cell and plasma cell densities compared to T cell densities in colorectal cancer.
    Karjalainen H; Sirniö P; Tuomisto A; Mäkinen MJ; Väyrynen JP
    Int J Colorectal Dis; 2023 Feb; 38(1):47. PubMed ID: 36800011
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer.
    Xu Y; Zhu Y; Xia H; Wang Y; Li L; Wan H; Zhang S; Xu A; Wang L; Gong J; Zhang P
    BMC Cancer; 2023 Feb; 23(1):131. PubMed ID: 36755222
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer.
    Wang W; Zhang Y; Liu J; Jing H; Lu K; Wang L; Zhu T; Xu Y; Bu D; Cheng M; Liu J; Shen W; Yao J; Huang S
    World J Surg Oncol; 2023 Feb; 21(1):31. PubMed ID: 36726115
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
    Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical Features and Long-term prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
    Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS
    Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combined Positive Score for Programmed Death Ligand-1 Expression and Inflammatory Microenvironment in Gastrointestinal Stromal Tumors.
    Herlea V; Roșulescu A; Calotă VC; Croitoru V; Stoica Mustafa E; Vasilescu C; Alexandrescu S; Dumitrașcu T; Popescu I; Dima SO; Sajin M
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208498
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 5.